Trisenox, an injectable form of ARSENIC

The FDA just approved Trisenox, an injectable form of ARSENIC.

Trisenox (arsenic trioxide) is for second-line therapy of acute promyelocytic leukemia. It's very effective...up to 70% remission in patients who don't do well on standard chemotherapy.

Trisenox has an interesting origin. Scientists discovered arsenic was a common ingredient in some traditional Chinese remedies for leukemia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote